• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Prescription Drug Diversion and Pain

Prescription Drug Diversion and Pain

History, Policy, and Treatment

9780199981830
386.10 zł
347.49 zł Save 38.61 zł Tax included
Lowest price within 30 days before promotion: 347.49 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Prescription Drug Diversion and Pain provides an interdisciplinary overview of medications used to treat chronic pain, specifically the benefits and risks that are posed by long-term opioids use. These essential pain-relieving medications must be carefully managed to prevent serious side effects that may include physical dependence, addiction, and even death, which has led in recent years to increased attention on the development of alternative treatments for chronic pain.This book not only offers a single, comprehensive source for understanding the specialized field of the opioid crisis, but also addresses provocative topics including how pain drugs came to be regulated by the U.S. Government and the rarely-discussed aggressive marketing behind the spread of these drugs.Chapters are written by expert contributors from diverse backgrounds in medicine, psychiatry, pharmacy, nursing, health law, and ethics. Prescription Drug Diversion and Pain is a must-read for healthcare professionals, caregivers, policy makers, regulatory officials, law enforcement, and those in the pharmaceutical industry seeking to address the current and future opioid crisis.
Product Details
OUP USA
87923
9780199981830
9780199981830

Data sheet

Publication date
2018
Issue number
1
Cover
paperback
Pages count
272
Dimensions (mm)
178 x 254
Weight (g)
499
  • John F. Peppin, John J. Coleman, and Kelly K. Dineen; Chapter 1: Opioid Medications: Old Wine in New Bottles; Timothy Atkinson, John J. Coleman, and Jeffrey Fudin; Chapter 2: Legal Regulation of Prescription Opioids and Prescribers; Kelly K. Dineen and Adam J. Ruggles; Chapter 3: Monitoring Prescriptions, Third-Party Healthcare Payers, Prescription Benefit Managers, and Private Sector Policy Options; John J. Coleman; Chapter 4: Whatever Happened to the Decade of Pain Control and Research?; John J. Coleman; Chapter 5: Evaluation and Treatment of the Chronic Pain Patient: Practice and Complexity; John F. Peppin, Pravardhan Birthi, Bill H. McCarberg, and Yvonne DArcy; Chapter 6: An Overview of the Abuse Potential of Non-Opioids: Sedatives, Hypnotics, and Stimulants; Christopher M. Herndon and Kelly N. Gable; Chapter 7: Psychiatry and Chronic Pain: An Associative Connection; Hani Raoul Khouzam; Chapter 8: Managing Pain in Patients with a History of a Substance Use Disorder: Challenges and Opportunities; Martin D. Cheatle; Chapter 9: Special Populations; Kelly K. Dineen; Chapter 10: The Demise of Interdisciplinary Chronic Pain Management and Its Relationship to the Scourge of Prescription Opioid Diversion and Abuse; Michael E. Schatman; Chapter 11: Pain Management Assessment Beyond the Physician Encounter: Urine Drug Monitoring and Patient Agreements; Anand C. Thakur; Epilogue; John F. Peppin, John J. Coleman, and Kelly K. Dineen;
Comments (0)